Anti-Serpin-A5 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the amino-terminal region of mature human Serpin-A5, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Monkey
UniProt
P05154
Size
100ug
Cat. #
RP2SerpinA5

In stock

SKU
RP-SerpinA5

Options

As low as: $130.00

Target Overview

Serpin-A5 (UniProt P05154), also known as protein C inhibitor (PCI) or plasminogen activator inhibitor-3 (PAI-3), is a secreted serine protease inhibitor of the serpin superfamily. This 406-amino acid protein functions in both intravascular and extravascular compartments, where it modulates coagulation, fibrinolysis, and reproductive physiology through heparin-dependent inhibition of multiple serine proteases. Serpin-A5 is present in blood plasma, seminal plasma, and urine. Its substrates include activated protein C, thrombin, factor XI, factor Xa, plasma kallikrein, tissue- and urinary-type plasminogen activators, and the sperm acrosomal protease acrosin. By irreversibly binding the serine active site of target proteases, Serpin-A5 plays dual hemostatic roles: it acts as a procoagulant by inhibiting the anticoagulant activated protein C, while simultaneously functioning as an anticoagulant by suppressing prothrombin and factor Xa. In the male reproductive tract, Serpin-A5 regulates sperm motility, fertilization, and semenogelin degradation. The protein also inhibits membrane-anchored serine proteases such as MPRSS7 and TMPRSS11E.

Background

Serpin-A5 occupies a unique position among serpins due to its ability to regulate both coagulation and anticoagulation pathways. In plasma, it inhibits activated protein C and thereby promotes coagulation, while simultaneously suppressing coagulation factors like factor Xa and prothrombin to limit clot formation. This dual regulatory function positions Serpin-A5 as a key modulator of hemostatic balance. The heparin-dependence of its activity adds an additional layer of regulation, allowing tissue-specific control of protease inhibition. In seminal plasma, where Serpin-A5 concentrations are particularly high, the protein prevents premature acrosome reaction by inhibiting acrosin, and it modulates the liquefaction of seminal coagulum by controlling plasminogen activator activity and semenogelin degradation during sperm transit into the female reproductive tract. Recent proteomic studies have identified Serpin-A5 in diverse clinical contexts. Kamau et al. (2026) reported persistent dysregulation of coagulation proteins, including Serpin-A5, in severely malnourished children, correlating with post-discharge mortality. Proteomic profiling in HIV-associated tuberculosis and chronic gout arthritis has also detected alterations in serpin expression patterns, suggesting roles in inflammation and immune modulation beyond classical hemostasis. The serpin's broad substrate specificity and presence in multiple body fluids make it a useful marker in proteomic surveys of coagulation, inflammation, and reproductive function. Three rabbit polyclonal antibodies raised against the amino-terminal region of mature Serpin-A5 are available from Triple Point Biologics. These reagents are validated for Western blot, with predicted cross-reactivity in non-human primates. The amino-terminal immunogen region is conserved across mammalian orthologs, supporting broader comparative studies.

References

  1. Kamau B et al (2026) Persistent immune, coagulation and cardiac dysregulation are correlated with later post-discharge mortality in children with severe malnutrition. BMC Med. PubMed · 10.1186/s12916-026-04647-9
  2. Ross JE et al (2026) Proteomic Immune Signatures of Severe HIV-Associated Tuberculosis in Sub-Saharan Africa: A Prospective, Multicenter Analysis from Uganda. medRxiv. PubMed · 10.64898/2025.12.31.25343299
  3. Zhu G et al (2025) Multi-Omics Mechanism of Chronic Gout Arthritis and Discovery of the Thyroid Hormone-AMPK-Taurine Metabolic Axis. Cells. PubMed · 10.3390/cells15010041

Additional Specifications

Gene Symbol SERPINA5
UniProt ID P05154
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Monkey
Pack Size 100ug
Immunogen (Amino end mature Serpin-A5)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 26-76.
Immunogen (Helix 4 to Helix 5)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 185-250.
Immunogen (Second heparin binding site)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 260-310.
Alternate Names Serpin-A5, SERPINA5, Plasma serine protease inhibitor, Protein C inhibitor, PCI, Plasminogen activator inhibitor 3, PAI-3, PAI3, Acrosomal serine protease inhibitor, Serpin A5

Frequently Asked Questions

What molecular weight should I expect for Serpin-A5 on a Western blot?

Serpin-A5 migrates at approximately 57 kDa on reducing SDS-PAGE, slightly above its predicted molecular weight of 46 kDa due to N-linked glycosylation at three consensus sites. You may observe a diffuse or doublet band reflecting glycosylation heterogeneity, particularly in plasma samples. If you treat lysates with PNGase F or other deglycosylation enzymes, the band should sharpen and shift toward 46 kDa. Some tissues and cell lines secrete less heavily glycosylated forms, so band appearance can vary by sample source.

What dilution should I start with for Western blot and IHC with this Serpin-A5 antibody?

For Western blot, we recommend starting at 1:1000 dilution in blocking buffer, which works well for plasma and conditioned media samples where Serpin-A5 is abundant. For IHC on formalin-fixed paraffin-embedded tissue, begin with 1:200 to 1:500 after antigen retrieval in citrate buffer. Serpin-A5 expression is relatively high in liver, kidney, and reproductive tissues, so you may be able to push dilutions higher. Always include a no-primary control and titrate against your specific sample type to balance signal and background.

Does this antibody recognize both free Serpin-A5 and protease-complexed forms?

This polyclonal antibody is raised against a broad epitope spanning residues of the Serpin-A5 protein and should recognize both free inhibitor and covalent serpin-protease complexes. In plasma samples analyzed by non-reducing Western blot, you may detect higher-molecular-weight bands representing Serpin-A5 bound to activated protein C, thrombin, or other target proteases. These complexes are SDS-stable but dissociate under reducing conditions. If you are specifically studying complex formation, run samples non-reduced and expect bands above 100 kDa depending on the protease partner.

Is this Serpin-A5 antibody validated for non-human primate samples?

The antibody is validated for human Serpin-A5 and shows potential cross-reactivity with monkey samples based on sequence homology, but we have not formally validated it in Old World or New World primate species. Human and cynomolgus macaque Serpin-A5 share approximately 95 percent amino acid identity, so cross-reactivity is likely. If you are working with non-human primate plasma or tissue, we recommend running a pilot Western blot alongside human positive control lysate to confirm signal at the expected molecular weight before committing to larger experiments.

What sample types are best for detecting endogenous Serpin-A5 expression?

Serpin-A5 is most abundant in human plasma, where it circulates at 4 to 5 micrograms per milliliter, and in seminal plasma at even higher concentrations. Liver hepatocytes are the primary biosynthetic source, so liver lysates serve as excellent positive controls. You will also detect Serpin-A5 in kidney, placenta, and male reproductive tissues. For cell culture work, HepG2 and other hepatoma lines secrete Serpin-A5 into conditioned medium. Urine contains lower levels, so concentrate samples by ultrafiltration or immunoprecipitation if analyzing urinary Serpin-A5.

Can I use this antibody to distinguish Serpin-A5 from other serpin family members?

Yes, this antibody is raised against Serpin-A5-specific sequences and does not cross-react with closely related serpins such as alpha-1-antitrypsin, alpha-1-antichymotrypsin, or antithrombin based on our internal screens. Serpin family members share structural homology but differ in reactive center loop and heparin-binding domains. If you are working with crude plasma or tissue extracts containing multiple serpins, you should see a single clean band at 57 kDa for Serpin-A5. Always include a recombinant Serpin-A5 standard or well-characterized positive control lysate to confirm specificity in your system.

How should I store this Serpin-A5 antibody and how long is it stable?

Store the antibody at minus 20 degrees Celsius in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titre and increase aggregation. The antibody is supplied in phosphate-buffered saline with glycerol and a preservative, stable for at least 12 months from the date of receipt when stored properly. For day-to-day use, keep a working aliquot at 4 degrees Celsius for up to one month. Do not store diluted antibody in blocking buffer for more than a few days, as carrier proteins can promote microbial growth and proteolysis.

What controls should I include when using this Serpin-A5 antibody in Western blot experiments?

Include a positive control such as human plasma diluted 1:100 in sample buffer, recombinant Serpin-A5 protein, or HepG2 cell lysate known to express Serpin-A5. Run a negative control lane with sample type expected to lack Serpin-A5, or use lysate from cells with SERPINA5 knockdown if available. A no-primary antibody control on a duplicate blot will confirm that secondary antibody is not generating off-target signal. If studying protease complexes, compare reduced and non-reduced samples side-by-side to distinguish free Serpin-A5 from high-molecular-weight complexes.

Validation imagery coming soon

Western blot validation figures for RP-SerpinA5 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • Serpin-A5
  • SERPINA5
  • Plasma serine protease inhibitor
  • Protein C inhibitor
  • PCI
  • Plasminogen activator inhibitor 3
  • PAI-3
  • PAI3
  • Acrosomal serine protease inhibitor
  • Serpin A5
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →